STIHL Honors Envalior as ”Supplier of the year 2022

STIHL has named LANXESS Performance Materials GmbH, which is now part of Envalior, as one of its “Suppliers of the Year 2022” alongside four other companies. The family company has been honoring suppliers for outstanding performance in terms of quality, technology, innovation, service, and value for money since 1990. The awards were presented on June 28, 2023, at the recently opened STIHL Brand World in Waiblingen by Anke Kleinschmit, Executive Board Member for Research and Development, and Marc Moser, Senior Vice President and Head of Global Purchasing. Among other things, Envalior supplies STIHL with Durethan®-brand polyamide compounds – in some cases in customized shades.

Long-standing, pancontinental partnership
“STIHL, a long-standing partner of ours, was particularly appreciative of our reliable, fast and flexible supply of products and services to all of its locations around the world despite the global supply chain disruption,” said Tim Albert, Sales Director for Germany, Austria and Switzerland at Envalior. This success is based on the fact that Envalior and its production has a pancontinental presence and is therefore close to its international customers everywhere. “Moreover, our product and development expertise is available in all major economic areas. We can therefore provide our partners with targeted and extensive support wherever they are,” explains Dr. Thomas Brackemeyer, Vice President Business, Performance Materials, at Envalior. For example, Envalior operates compounding facilities for Durethan® polyamides and Pocan® polyesters in Krefeld-Uerdingen in Germany, in Wuxi in China, in Gastonia in the U.S. and in Porto Feliz in Brazil. It also has a dense network of regional and local centers for product and application development. For example, Envalior operates these service centers in Wuxi, Hong Kong, Porto Feliz and in Jhagadia in India.

STIHL develops, manufactures, and sells power tools for forestry, agriculture, landscaping, construction, and home gardeners. It has been the world’s top-selling chainsaw brand since 1971.

Envalior is a new company formed as a result of the merger of two industry leaders, DSM Engineering Materials (DEM) and LANXESS High Performance Materials (HPM). It is one of the world’s leading manufacturers of high performance engineering plastics.

SourceSTIHL

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.